Article
Cross-assay RNA modeling reveals cancer biomarkers
2026-05-05
Abstract excerpt
The clinical heterogeneity of cancer poses a major challenge for precision medicine. Limited cohort sizes across evolving assay platforms impede reliable biomarker discovery. Here, we systematically evaluate how to integrate data from four transcriptomics platforms: bulk and single-cell (sc) RNA sequencing (RNA-seq), NanoString, and microarray for predictive modeling in cancer. We use high-grade serous carcinoma (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9474fe70-67f1-5869-89b1-8b9871166cfc
- DOI
- 10.64898/2026.04.30.722009
